Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-18

被引:1378
作者
Fisher, B
Brown, A
Mamounas, E
Wieand, S
Robidoux, A
Margolese, RG
Cruz, AB
Fisher, ER
Wickerham, DL
Wolmark, N
DeCillis, A
Hoehn, JL
Lees, AW
Dimitrov, NV
机构
[1] UNIV PITTSBURGH, SHADYSIDE HOSP, GRAD SCH PUBL HLTH, DEPT BIOSTAT, PITTSBURGH, PA 15260 USA
[2] UNIV PITTSBURGH, SHADYSIDE HOSP, DEPT SURG, PITTSBURGH, PA 15260 USA
[3] ALLEGHENY GEN HOSP, PITTSBURGH, PA 15212 USA
[4] MT SINAI CTR BREAST HLTH, CLEVELAND, OH USA
[5] ST LUC HOSP, MONTREAL, PQ, CANADA
[6] MCGILL UNIV, JEWISH GEN HOSP, MONTREAL, PQ H3T 1E2, CANADA
[7] CROSS CANC INST, EDMONTON, AB T6G 1Z2, CANADA
[8] UNIV TEXAS SAN ANTONIO, SAN ANTONIO, TX 78285 USA
[9] MARSHFIELD CLIN FDN MED RES & EDUC, MARSHFIELD, WI 54449 USA
[10] MICHIGAN STATE UNIV, E LANSING, MI 48824 USA
关键词
D O I
10.1200/JCO.1997.15.7.2483
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To determine whether preoperative doxorubicin and cyclophosphamide (AC) permits more lumpectomies to be performed and decreases the incidence of positive nodes in women with primary breast cancer. Patients and Methods: Women (n = 1,523) were randomized to National Surgical Adjuvant Breast and Bowel Project (NSABP) B-18; 759 eligible patients received postoperative AC and 747, preoperative AC, The clinical size of breast and axillary tumors was determined before each of four cycles of AC and before surgery, Tumor response to preoperative therapy was clinically complete (cCR), partial (cPR), stable (cSD), or progressive disease (cPD). Tissue from patients with a cCR was evaluated for a pathologic complete response (pCR). Results: Breast tumor size was reduced in 80% of patients after preoperative therapy; 36% had a cCR. Tumor size and clinical nodal status were independent predictors of cCR, Twenty-six percent of women with a cCR had a pCR. Clinical nodal response occurred in 89% of node-positive patients: 73% had a cCR and 44% of those had a pCR, There was a 37% increase in the incidence of pathologically negative nodes. Before randomization, lumpectomy was proposed for 86% of women with tumors less than or equal to 2 cm, 70% with tumors 2.1 to 5.0 cm, and 3% with tumors greater than or equal to 5.1 cm. Clinical tumor size and nodal status influenced the physician's decision, Overall, 12% more lumpectomies were performed in the preoperative group; in women with tumors greater than or equal to 5.1 cm, there was a 175% increase. Conclusion: Preoperative therapy reduced the size of most breast tumors and decreased the incidence of positive nodes. The greatest increase in lumpectomy after preoperative therapy occurred in women with tumors greater than or equal to 5 cm, since women with tumors less than 5 cm were already lumpectomy candidates, Preoperative therapy should be considered for the initial management of breast rumors judged too large for lumpectomy. (C) 1997 by American Society of Clinical Oncology.
引用
收藏
页码:2483 / 2493
页数:11
相关论文
共 34 条
  • [1] NEOADJUVANT CHEMOTHERAPY IN 126 OPERABLE BREAST CANCERS
    BELEMBAOGO, E
    FEILLEL, V
    CHOLLET, P
    CURE, H
    VERRELLE, P
    KWIATKOWSKI, F
    ACHARD, JL
    LEBOUEDEC, G
    CHASSAGNE, J
    BIGNON, YJ
    DELATOUR, M
    LAFAYE, C
    DAUPLAT, J
    [J]. EUROPEAN JOURNAL OF CANCER, 1992, 28A (4-5) : 896 - 900
  • [2] PRIMARY CHEMOTHERAPY TO AVOID MASTECTOMY IN TUMORS WITH DIAMETERS OF 3 CENTIMETERS OR MORE
    BONADONNA, G
    VERONESI, U
    BRAMBILLA, C
    FERRARI, L
    LUINI, A
    GRECO, M
    BARTOLI, C
    DEYOLDI, GC
    ZUCALI, R
    RILKE, F
    ANDREOLA, S
    SILVESTRINI, R
    DIFRONZO, G
    VALAGUSSA, P
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (19) : 1539 - 1545
  • [3] PRIMARY CHEMOTHERAPY IN SURGICALLY RESECTABLE BREAST-CANCER
    BONADONNA, G
    VALAGUSSA, P
    ZUCALI, R
    SALVADORI, B
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 1995, 45 (04) : 227 - 243
  • [4] FISHER B, 1981, SURG GYNECOL OBSTET, V152, P765
  • [5] FISHER B, 1983, CANCER RES, V43, P1488
  • [6] ON THE UNDERUTILIZATION OF BREAST-CONSERVING SURGERY FOR THE TREATMENT OF BREAST-CANCER
    FISHER, B
    ORE, L
    [J]. ANNALS OF ONCOLOGY, 1993, 4 (02) : 96 - 98
  • [7] LUMPECTOMY AND AXILLARY DISSECTION FOR BREAST-CANCER - SURGICAL, PATHOLOGICAL, AND RADIATION CONSIDERATIONS
    FISHER, B
    WOLMARK, N
    FISHER, ER
    DEUTSCH, M
    [J]. WORLD JOURNAL OF SURGERY, 1985, 9 (05) : 692 - 698
  • [8] FORREST APM, 1986, LANCET, V2, P840
  • [9] FORREST APM, 1991, MED MANAGEMENT BREAS, P273
  • [10] FREI E, 1982, CANCER, V50, P1979, DOI 10.1002/1097-0142(19821115)50:10<1979::AID-CNCR2820501002>3.0.CO